Sterling Capital Management’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
Sterling Capital Management's UPB Position: Q3 2026 in Review
Sterling Capital Management increased its Upstream Bio (UPB) stake by 4.2% in Q3 2026, buying an estimated $196 and bringing the position to 740 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2962.
Sterling Capital Management first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $52.1K in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- Sterling Capital Management held 740 shares of Upstream Bio worth $3.9K as of Q3 2026.
- Sterling Capital Management bought 30 Upstream Bio shares in Q3 2026, an estimated $196.
- Upstream Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2962 holding.
- Sterling Capital Management first reported a position in Upstream Bio in Q4 2024 and has held it in 8 quarters since.
- Sterling Capital Management's Upstream Bio position peaked at $52.1K in Q4 2025.
- 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.